Financial Times FT.com

Resources

Principal content

The Mergermarket Group’s products and services provide the global advisory and corporate communities with intelligence and analysis, leading to real revenues for clients. As part of a new partnership with FT.com, Mergermarket offers 4 new articles daily, from Monday to Friday, to FT.com readers from a selection of its products. For further information on Mergermarket’s products please see the About Us section below.

This content is written, edited and published solely by The Mergermarket Group and is distributed by FT.com. All queries regarding the content should be directed to: cw@mergermarket.com

About us

--------------------------------------------------------------------------------------------------------

Micrel unlikely to see Obrem-led upheaval at 20 May EGM; near-term consolidation also doubtful as company not considered ’must-have’ - sources

A person close to Micrel claimed it has heard nothing but support from its shareholders, but said there have been talks with Obrem. by dealReporter

Imclone’s Erbitux BMS-099 trial not powered to show overall survival, FLEX remains pivotal registrational trial

Imclone’s Erbitux BMS-099 trial was not powered to show overall survival and expectations for conclusive data remain low, said Dr Eric Rowinsky, executive vice president and chief medical officer. by Pharmawire

Enodis: ITW sees easier antitrust than Manitowoc; Manitowoc still considering counter bid

Illinois Tool Works is not expecting significant antitrust issues for its proposed takeover of Enodis, according to an ITW source. by dealReporter

Genentech’s Avastin study should evaluate drug’s effect on overall survival as primary endpoint, physicians say

Genentech’s study of Avastin in patients with colorectal cancer in the adjuvant setting should examine the drug’s effect on a primary endpoint of overall survival, physicians said. by Pharmawire

La Caixa, Caixa Catalunya seen benefiting from possible consolidation of Spanish savings bank market - analysis

The next round of consolidation in the Spanish banking market is likely to come among unlisted regional savings banks, said experts in the sector. by mergermarket

Huntsman/Hexion kick off epoxy divestiture sale in hopes of closing deal by 4 July – sources

Huntsman and Hexion have commenced an auction process for numerous specialty epoxy businesses that need to be divested to facilitate the closing of the proposed merger, it is understood. by dealReporter

Rio Tinto: BHP and China at odds over Chinese antitrust requirements, sources say

BHP, the dual-listed Australian mining company, does not intend to notify Chinese anti-monopoly authorities as part of its antitrust clearance process, according to two sources close to BHP. by dealreporter

Penn National banks go to work on credit agreement this month for deal with little incentive to complete - sources

The banks funding Penn National’s take-private have started working on the finer details of the credit agreement with Fortress and Centerbridge, said one source close to the situation. by dealReporter

Kazakhmys: ENRC had been considering ‘low ball’ informal approach for weeks, may walk away

ENRC had been considering making an approach to Kazakhmys below its share price for at least three weeks. by dealReporter

Post asking for USD 41 or 42 despite recent drop in share price, source says

Asking price is about USD 1 per share more than what sources said bidders Starwood Capital was offering last week. by dealReporter

Actelion could strike almorexant deal soon; GSK and Novartis remain

Fourth column content

World equities latest

Fourth column content

 CLASSIFIED 

Jobs

Search
Type your search criteria below:

Chief Executive

Medical Defence Union

Recruiters

FT.com can deliver talented individuals across all industries around the world

Post a job now